Delivery Order SPE2DB22D2007-SPE2DB25FJ0JH
Award Date
4/1/25
Potential Completion Date
4/2/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,359.98, is for the delivery of QUILLIVANT XR 25 MG/5 ML SUSP 60ML, a pharmaceutical product, with a completion date of December 13, 2023. The contract is a Delivery Order placed under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,592.08, is for the delivery of QUILLIVANT XR 25 MG/5 ML SUSP 60ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 14, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,855.07, is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 24, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC)...
This is a $1,550.28 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 60ML, a pharmaceutical product, with a completion date of March 17, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,078.07 firm-fixed-price delivery order is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML, a pharmaceutical product. The contract has an ultimate completion date of March 12, 2025 and was awarded on March 11, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,196.51, is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 180ML, a pharmaceutical product. The contract has an ultimate completion date of March 31, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $1,315.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of QUILLIVANT XR 25 MG/5 ML SUSP 120ML. The contract is a delivery order under an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,019.01, is for the supply of QUILLIVANT XR ORAL SUSP 180ML 5MG/ML, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 180ML. The $1,835.06 firm fixed price contract has a period of performance through May 20, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This federal contract award, valued at $1,942.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 180ML, a pharmaceutical product, and is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive...